Life Sciences

Agar Scientific



Transaction type Private M&A

Sector Life Sciences

“We’re excited to be joining the Calibre Scientific family, who will enable us to further accelerate our long-term strategic growth objectives. The finnCap Cavendish team has achieved a fantastic result for our Shareholders. Their wealth of sector expertise, professionalism and unwavering dedication throughout the process were instrumental in achieving a successful completion.”

Darren Likely, CEO, Agar

The deal was led by Michael Jewell, Partner at finnCap Cavendish, supported by Sam Kavanagh, Associate Director and MJ Murphy, Associate.

“We are delighted to have advised Agar’s management team and Foresight on this deal. It was a pleasure working with them and we are pleased to have secured the right cultural and strategic buyer for the business for the long-term. This transaction also highlights our sector-leading credentials in the life sciences and healthcare industries and demonstrates our strong capabilities to transact cross-border M&A deals.”